Primary Vitreoretinal Lymphoma in HIV Infection

References

• Chan CC, Rubenstein JL, Coupland SE, et al. Primary vitreoretinal lymphoma: a report from an international primary central nervous system lymphoma collaborative group symposium. Oncologist. 2011;16(11):1589–1599. doi:10.1634/theoncologist.2011-0210.
   PubMed Web of Science ®Google Scholar
• Grimm SA, Pulido JS, Jahnke K, et al. Primary intraocular lymphoma: an international primary central nervous system lymphoma collaborative group report. Ann Oncol. 2007;18(11):1851–1855. doi:10.1093/annonc/mdm340.
   PubMed Web of Science ®Google Scholar
• Aronow ME, Portell CA, Sweetenham JW, Singh AD. Uveal lymphoma: clinical features, diagnostic studies, treatment selection, and outcomes. Ophthalmology. 2014;121(1):334–341. doi:10.1016/j.ophtha.2013.09.004.
   PubMed Web of Science ®Google Scholar
• Matthews GF P, Scaravilli F, Miller RF. Ocular and fulminant cerebral lymphoma in AIDS. Int J STD AIDS. 1999;10(7):483–486. doi:10.1258/0956462991914375.
   PubMed Web of Science ®Google Scholar
• Mittra RA, Pulido JS, Hanson GA, Kajdacsy-Balla A, Brummitt CF. Primary ocular Epstein-Barr virus-associated non-Hodgkin’s lymphoma in a patient with AIDS: a clinicopathologic report. Retina. 1999;19(1):45–50. doi:10.1097/00006982-199901000-00007.
   PubMed Web of Science ®Google Scholar
• Ormerod LD, Puklin JE. AIDS-associated intraocular lymphoma causing primary retinal vasculitis. Ocul Immunol Inflamm. 1997;5(4):271–278. doi:10.3109/09273949709085068.
   PubMed Web of Science ®Google Scholar
• Rivero ME, Kuppermann BD, Wiley CA, et al. Acquired immunodeficiency syndrome-related intraocular B-cell lymphoma. Arch Ophthalmol. 1999;117(5):616–622. doi:10.1001/archopht.117.5.616.
   PubMedGoogle Scholar
• Babu K, Murthy KR, Krishnakumar S. Two successive ocular malignancies in the same eye of a HIV-positive patient: a case report. Ocul Immunol Inflamm. 2010;18(2):101–103. doi:10.3109/09273940903374237.
   PubMed Web of Science ®Google Scholar
• Matzkin DC, Slamovits TL, Rosenbaum PS. Simultaneous intraocular and orbital non-Hodgkin lymphoma in the acquired immune deficiency syndrome. Ophthalmology. 1994;101(5):850–855. doi:10.1016/S0161-6420(94)31248-6.
   PubMed Web of Science ®Google Scholar
• Schanzer MC, Font RL, O’Malley RE. Primary ocular malignant lymphoma associated with the acquired immune deficiency syndrome. Ophthalmology. 1991;98(1):88–91. doi:10.1016/S0161-6420(91)32335-2.
   PubMed Web of Science ®Google Scholar
• Seerp Baarsma G, Roland Smit LM. Presumed intraocular lymphoma in a 60-year-old man with AIDS. Eur J Ophthalmol. 1992;2(4):203–204. doi:10.1177/112067219200200408.
   PubMedGoogle Scholar
• Stanton CA, Sloan B 3rd, Slusher MM, Greven CM. Acquired immunodeficiency syndrome-related primary intraocular lymphoma. Arch Ophthalmol. 1992;110(11):1614–1617. doi:10.1001/archopht.1992.01080230114034.
   PubMedGoogle Scholar
• Levasseur SD, Wittenberg LA, White VA, Vitreoretinal lymphoma A. 20-year review of incidence, clinical and cytologic features, treatment, and outcomes. JAMA Ophthalmol. 2013;131(1):50–55. doi:10.1001/jamaophthalmol.2013.569.
   PubMed Web of Science ®Google Scholar
• Centers for Disease C, Prevention. Revised surveillance case definition for HIV infection–United States, 2014. MMWR Recomm Rep. 2014;63(RR–03): 1–10.
   Google Scholar
• Shiels MS, Pfeiffer RM, Hall HI, et al. Proportions of Kaposi sarcoma, selected non-Hodgkin lymphomas, and cervical cancer in the United States occurring in persons with AIDS, 1980-2007. JAMA. 2011;305(14):1450–1459. doi:10.1001/jama.2011.396.
   PubMed Web of Science ®Google Scholar
• Gibson TM, Morton LM, Shiels MS, Clarke CA, Engels EA. Risk of non-Hodgkin lymphoma subtypes in HIV-infected people during the HAART era: a population-based study. AIDS. 2014;28(15):2313–2318. doi:10.1097/QAD.0000000000000428.
   PubMedGoogle Scholar
• Levine AM, Sullivan-Halley J, Pike MC, et al. Human immunodeficiency virus-related lymphoma. Prognostic factors predictive of survival. Cancer. 1991;68(11):2466–2472. doi:10.1002/1097-0142(19911201)68:11<2466::AID-CNCR2820681124>3.0.CO;2-G.
   PubMed Web of Science ®Google Scholar
• Herndier BG, Kaplan LD, McGrath MS. Pathogenesis of AIDS lymphomas. AIDS. 1994;8(8):1025–1049. doi:10.1097/00002030-199408000-00003.
   PubMed Web of Science ®Google Scholar
• Cummings TJ, Stenzel TT, Klintworth G, Jaffe GJ. Primary intraocular T-cell-rich large B-cell lymphoma. Arch Pathol Lab Med. 2005;129(8):1050–1053. doi:10.1043/1543-2165(2005)129[1050:PITLBL]2.0.CO;2.
   PubMed Web of Science ®Google Scholar
• MacMahon EM, Glass JD, Hayward SD, et al. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet. 1991;338(8773):969–973. doi:10.1016/0140-6736(91)91837-K.
   PubMed Web of Science ®Google Scholar
• Cingolani A, De Luca A, Larocca LM, et al. Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. J Natl Cancer Inst. 1998;90(5):364–369. doi:10.1093/jnci/90.5.364.
   PubMedGoogle Scholar
• Lyons SF, Liebowitz DN. The roles of human viruses in the pathogenesis of lymphoma. Semin Oncol. 1998;25:461–475.
   PubMed Web of Science ®Google Scholar
• Gasser O, Bihl FK, Wolbers M, et al. HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts. PLoS Med. 2007;4(3):e96. doi:10.1371/journal.pmed.0040096.
   PubMed Web of Science ®Google Scholar
• Chan CC, Shen DF, Whitcup SM, Nussenblatt RB. Detection of human herpesvirus-8 and Epstein-Barr virus DNA in primary intraocular lymphomas. Blood. 1999;93(8):2749–2751. doi:10.1182/blood.V93.8.2749.
   PubMed Web of Science ®Google Scholar
• Chi D, Henry J, Kelley J, Thorpe R, Smith JK, Krishnaswamy G. The effects of HIV infection on endothelial function. Endothelium. 2000;7(4):223–242. doi:10.3109/10623320009072210.
   PubMed Web of Science ®Google Scholar
• Smith JR, Henderson WW, Rosenbaum JT, Neuwelt EA, Moses AV. Cultured human endothelial cells expressing HIV-1 Vpu and Tat support the expansion of malignant B cells from primary central nervous system lymphoma. Br J Ophthalmol. 2008;92(2):297–299. doi:10.1136/bjo.2007.119461.
   PubMed Web of Science ®Google Scholar
• Chan CC, Shen D, Hackett JJ, Buggage RR, Tuaillon N. Expression of chemokine receptors, CXCR4 and CXCR5, and chemokines, BLC and SDF-1, in the eyes of patients with primary intraocular lymphoma. Ophthalmology. 2003;110(2):421–426. doi:10.1016/S0161-6420(02)01737-2.
   PubMed Web of Science ®Google Scholar
• Smith JR, Braziel RM, Paoletti S, Lipp M, Uguccioni M, Rosenbaum JT. Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothelium in primary central nervous system lymphoma. Blood. 2003;101(3):815–821. doi:10.1182/blood-2002-05-1576.
   PubMed Web of Science ®Google Scholar
• Smith JR, Falkenhagen KM, Coupland SE, Chipps TJ, Rosenbaum JT, Braziel RM. Malignant B cells from patients with primary central nervous system lymphoma express stromal cell-derived factor-1. Am J Clin Pathol. 2007;127(4):633–641. doi:10.1309/NUQHJ79BHWYD9TAF.
   PubMed Web of Science ®Google Scholar
• Rubenstein JL, Wong VS, Kadoch C, et al. CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma. Blood. 2013;121(23):4740–4748. doi:10.1182/blood-2013-01-476333.
   PubMed Web of Science ®Google Scholar
• Rothova A, Ooijman F, Kerkhoff F, Van Der Lelij A, Lokhorst HM. Uveitis masquerade syndromes. Ophthalmology. 2001;108(2):386–399. doi:10.1016/S0161-6420(00)00499-1.
   PubMed Web of Science ®Google Scholar
• Cassoux N, Merle-Beral H, Leblond V, et al. Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm. 2000;8(4):243–250. doi:10.1076/ocii.8.4.243.6463.
   PubMed Web of Science ®Google Scholar
• Hoffman PM, McKelvie P, Hall AJ, Stawell RJ, Santamaria JD. Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes. Eye (Lond). 2003;17(4):513–521. doi:10.1038/sj.eye.6700378.
   PubMed Web of Science ®Google Scholar
• Jahnke K, Korfel A, Komm J, et al. Intraocular lymphoma 2000-2005: results of a retrospective multicentre trial. Graefes Arch Clin Exp Ophthalmol. 2006;244(6):663–669. doi:10.1007/s00417-005-0138-9.
   PubMed Web of Science ®Google Scholar
• AlQahtani A, Touitou V, Cassoux N, et al. More than a masquerade syndrome: atypical presentations of vitreoretinal lymphomas. Ocul Immunol Inflamm. 2014;22(3):189–196. doi:10.3109/09273948.2013.835427.
   PubMed Web of Science ®Google Scholar
• Marchese A, Miserocchi E, Giuffre C, et al. Aurora borealis and string of pearls in vitreoretinal lymphoma: patterns of vitreous haze. Br J Ophthalmol. 2019. doi:10.1136/bjophthalmol-2018-313491.
   Web of Science ®Google Scholar
• Lee J, Kim SW, Kim H, Lee CS, Kim M, Lee SC. Differential diagnosis for vitreoretinal lymphoma with vitreoretinal findings, immunoglobulin clonality tests, and interleukin levels. Retina. 2019;39(6):1165–1176. doi:10.1097/IAE.0000000000002127.
   PubMed Web of Science ®Google Scholar
• Velez G, de Smet MD, Whitcup SM, Robinson M, Nussenblatt RB, Chan CC. Iris involvement in primary intraocular lymphoma: report of two cases and review of the literature. Surv Ophthalmol. 2000;44(6):518–526. doi:10.1016/S0039-6257(00)00118-1.
   PubMed Web of Science ®Google Scholar
• Grimm SA, McCannel CA, Omuro AM, et al. Primary CNS lymphoma with intraocular involvement: international PCNSL Collaborative Group Report. Neurology. 2008;71(17):1355–1360. doi:10.1212/01.wnl.0000327672.04729.8c.
   PubMed Web of Science ®Google Scholar
• Rautenbach W, Steffen J, Smit D, Lecuona K, Esterhuizen T. Patterns of uveitis at two university-based referral centres in Cape Town, South Africa. Ocul Immunol Inflamm. 2019;27(6):868–874. doi:10.1080/09273948.2017.1391954.
   Web of Science ®Google Scholar
• Whitcup SM, de Smet MD, Rubin BI, et al. Intraocular lymphoma. Clinical and histopathologic diagnosis. Ophthalmology. 1993;100(9):1399–1406. doi:10.1016/S0161-6420(93)31469-7.
   PubMed Web of Science ®Google Scholar
• Peterson K, Gordon KB, Heinemann MH, DeAngelis LM. The clinical spectrum of ocular lymphoma. Cancer. 1993;72:843–849.
   PubMed Web of Science ®Google Scholar
• Barry RJ, Tasiopoulou A, Murray PI, et al. Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis. Br J Ophthalmol. 2018;102(10):1362–1366. doi:10.1136/bjophthalmol-2017-311612.
   PubMed Web of Science ®Google Scholar
• Deak GG, Goldstein DA, Zhou M, Fawzi AA, Jampol LM. Vertical hyperreflective lesions on optical coherence tomography in vitreoretinal lymphoma. JAMA Ophthalmol. 2019;137(2):194–198. doi:10.1001/jamaophthalmol.2018.5835.
   PubMed Web of Science ®Google Scholar
• Fardeau C, Lee CP, Merle-Beral H, et al. Retinal fluorescein, indocyanine green angiography, and optic coherence tomography in non-Hodgkin primary intraocular lymphoma. Am J Ophthalmol. 2009;147(5):886–894. 894 e881. doi:10.1016/j.ajo.2008.12.025.
   PubMed Web of Science ®Google Scholar
• Lavine JA, Singh AD, Sharma S, Baynes K, Lowder CY, Srivastava SK. Ultra-widefield multimodal imaging of primary vitreoretinal lymphoma. Retina. 2019;39(10):1861–1871. doi:10.1097/IAE.0000000000002260.
   Web of Science ®Google Scholar
• Ishida T, Ohno-Matsui K, Kaneko Y, et al. Fundus autofluorescence patterns in eyes with primary intraocular lymphoma. Retina. 2010;30(1):23–32. doi:10.1097/IAE.0b013e3181b408a2.
   PubMed Web of Science ®Google Scholar
• Whitcup SM, Chan CC, Buggage RR, Nussenblatt RB, Byrnes GA, Rubin BI. Improving the diagnostic yield of vitrectomy for intraocular lymphoma. Arch Ophthalmol. 2000;118:446.
   PubMedGoogle Scholar
• Coupland SE, Bechrakis NE, Anastassiou G, et al. Evaluation of vitrectomy specimens and chorioretinal biopsies in the diagnosis of primary intraocular lymphoma in patients with Masquerade syndrome. Graefes Arch Clin Exp Ophthalmol. 2003;241(10):860–870. doi:10.1007/s00417-003-0749-y.
   PubMed Web of Science ®Google Scholar
• Coupland SE, Perez-Canto A, Hummel M, Stein H, Heimann H. Assessment of HOPE fixation in vitrectomy specimens in patients with chronic bilateral uveitis (masquerade syndrome). Graefes Arch Clin Exp Ophthalmol. 2005;243(9):847–852. doi:10.1007/s00417-005-1166-1.
   PubMed Web of Science ®Google Scholar
• Karma A, von Willebrand EO, Tommila PV, Paetau AE, Oskala PS, Immonen IJ. Primary intraocular lymphoma: improving the diagnostic procedure. Ophthalmology. 2007;114(7):1372–1377. doi:10.1016/j.ophtha.2006.11.009.
   PubMed Web of Science ®Google Scholar
• Gonzales JA, Chan CC. Biopsy techniques and yields in diagnosing primary intraocular lymphoma. Int Ophthalmol. 2007;27(4):241–250. doi:10.1007/s10792-007-9065-6.
   PubMedGoogle Scholar
• Davis JL, Miller DM, Ruiz P. Diagnostic testing of vitrectomy specimens. Am J Ophthalmol. 2005;140(5):822–829. doi:10.1016/j.ajo.2005.05.032.
   PubMed Web of Science ®Google Scholar
• Mastropasqua R, Thaung C, Pavesio C, et al. The role of chorioretinal biopsy in the diagnosis of intraocular lymphoma. Am J Ophthalmol. 2015;160(6):1127–1132. e1121. doi:10.1016/j.ajo.2015.08.033.
   PubMed Web of Science ®Google Scholar
• Chan CC. Molecular pathology of primary intraocular lymphoma. Trans Am Ophthalmol Soc. 2003;101:275–292.
   PubMedGoogle Scholar
• Aliferis K, Chan CC, Donati G, Baglivo E. Intraocular lymphoma following a primary testicular lymphoma in remission for 10 years. Int Ophthalmol. 2008;28(6):439–440. doi:10.1007/s10792-007-9157-3.
   PubMedGoogle Scholar
• Kimura K, Usui Y, Goto H. Japanese Intraocular Lymphoma Study G. Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma. Jpn J Ophthalmol. 2012;56(4):383–389. doi:10.1007/s10384-012-0150-7.
   PubMed Web of Science ®Google Scholar
• Raja H, Salomao DR, Viswanatha DS, Pulido JS. Prevalence of Myd88 L265p mutation in histologically proven, diffuse large B-cell vitreoretinal lymphoma. Retina-J Ret Vit Dis. 2016;36(3):624–628.
   PubMed Web of Science ®Google Scholar
• Bonzheim I, Giese S, Deuter C, et al. High frequency of MYD88 mutations in vitreoretinal B-cell lymphoma: a valuable tool to improve diagnostic yield of vitreous aspirates. Blood. 2015;126(1):76–79. doi:10.1182/blood-2015-01-620518.
   PubMed Web of Science ®Google Scholar
• Hiemcke-Jiwa LS, Ten Dam-van Loon NH, Leguit RJ, et al. Potential diagnosis of vitreoretinal lymphoma by detection of MYD88 mutation in aqueous humor with ultrasensitive droplet digital polymerase chain reaction. JAMA Ophthalmol. 2018;136(10):1098–1104. doi:10.1001/jamaophthalmol.2018.2887.
   PubMed Web of Science ®Google Scholar
• Moulignier A, Lamirel C, Picard H, et al. Long-term AIDS-related PCNSL outcomes with HD-MTX and combined antiretroviral therapy. Neurology. 2017;89(8):796–804. doi:10.1212/WNL.0000000000004265.
   PubMed Web of Science ®Google Scholar
• Bakshi R. Neuroimaging of HIV and AIDS related illnesses: a review. Front Biosci. 2004;9:632–646. doi:10.2741/1256.
   PubMed Web of Science ®Google Scholar
• Skolasky RL, Dal Pan GJ, Olivi A, Lenz FA, Abrams RA, McArthur JC. HIV-associated primary CNS lymorbidity and utility of brain biopsy. J Neurol Sci. 1999;163(1):32–38. doi:10.1016/S0022-510X(98)00315-3.
   PubMed Web of Science ®Google Scholar
• Bossolasco S, Falk KI, Ponzoni M, et al. Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma. Clin Infect Dis. 2006;42(4):e21–25. doi:10.1086/499956.
   PubMed Web of Science ®Google Scholar
• Brandsma D, Bromberg JEC. Primary CNS lymphoma in HIV infection. Handb Clin Neurol. 2018;152:177–186.
   PubMedGoogle Scholar
• Riemens A, Bromberg J, Touitou V, et al. Treatment strategies in primary vitreoretinal lymphoma: a 17-center European collaborative study. JAMA Ophthalmol. 2015;133(2):191–197. doi:10.1001/jamaophthalmol.2014.4755.
   PubMed Web of Science ®Google Scholar
• Frenkel S, Hendler K, Siegal T, Shalom E. Pe’er J. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience. Brit J Ophthalmol. 2008;92(3):383–388. doi:10.1136/bjo.2007.127928.
   PubMed Web of Science ®Google Scholar
• Smith JR. Pe’er J, Belfort RN, et al. Proceedings of the association for research in vision and ophthalmology and champalimaud foundation ocular oncogenesis and oncology conference. Transl Vis Sci Technol. 2019;8(1):9. doi:10.1167/tvst.8.1.9.
   PubMed Web of Science ®Google Scholar
• Larkin KL, Saboo US, Comer GM, et al. Use of intravitreal rituximab for treatment of vitreoretinal lymphoma. Brit J Ophthalmol. 2014;98(1):99–103. doi:10.1136/bjophthalmol-2013-304043.
   PubMed Web of Science ®Google Scholar
• Hoffmann C, Tabrizian S, Wolf E, et al. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS. 2001;15(16):2119–2127. doi:10.1097/00002030-200111090-00007.
   PubMed Web of Science ®Google Scholar
• Bower M, Palfreeman A, Alfa-Wali M, et al. British HIV Association guidelines for HIV-associated malignancies 2014. HIV Med. 2014;15(Suppl 2):1–92. doi:10.1111/hiv.12136.
   Google Scholar
• Gupta NK, Nolan A, Omuro A, et al. Long-term survival in AIDS-related primary central nervous system lymphoma. Neuro Oncol. 2017;19(1):99–108. doi:10.1093/neuonc/now155.
   PubMed Web of Science ®Google Scholar
• Baumgartner JE, Rachlin JR, Beckstead JH, et al. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg. 1990;73(2):206–211. doi:10.3171/jns.1990.73.2.0206.
   PubMed Web of Science ®Google Scholar
• Spina M, Sparano JA, Jaeger U, Rossi G, Tirelli U. Rituximab and chemotherapy is highly effective in patients with CD20-positive non-Hodgkin’s lymphoma and HIV infection. AIDS. 2003;17(1):137–138. doi:10.1097/00002030-200301030-00024.
   PubMed Web of Science ®Google Scholar
• Bromberg JEC, Issa S, Bakunina K, et al. Rituximab in patients with primary CNS lymphoma (HOVON 105/ALLG NHL 24): a randomised, open-label, phase 3 intergroup study. Lancet Oncol. 2019;20(2):216–228. doi:10.1016/S1470-2045(18)30747-2.
   PubMed Web of Science ®Google Scholar
• Castellino A, Pulido JS, Johnston PB, et al. Role of systemic high-dose methotrexate and combined approaches in the management of vitreoretinal lymphoma: A single center experience 1990-2018. Am J Hematol. 2019;94(3):291–298. doi:10.1002/ajh.25350.
   PubMed Web of Science ®Google Scholar
• Klimova A, Heissigerova J, Rihova E, et al. Combined treatment of primary vitreoretinal lymphomas significantly prolongs the time to first relapse. Brit J Ophthalmol. 2018;102(11):1579–1585. doi:10.1136/bjophthalmol-2017-311574.
   PubMed Web of Science ®Google Scholar
• Marretta L, Stocker H, Drauz D, et al. Treatment of HIV-related primary central nervous system lymphoma with AZT high dose, HAART, interleukin-2 and foscarnet in three patients. Eur J Med Res. 2011;16(5):197–205. doi:10.1186/2047-783X-16-5-197.
   PubMed Web of Science ®Google Scholar
• Raez L, Cabral L, Cai JP, et al. Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2. AIDS Res Hum Retroviruses. 1999;15(8):713–719. doi:10.1089/088922299310809.
   PubMed Web of Science ®Google Scholar
• Bayraktar S, Bayraktar UD, Ramos JC, Stefanovic A, Lossos IS. Primary CNS lymphoma in HIV positive and negative patients: comparison of clinical characteristics, outcome and prognostic factors. J Neurooncol. 2011;101(2):257–265. doi:10.1007/s11060-010-0252-3.
   PubMed Web of Science ®Google Scholar
• Olszewski AJ, Fallah J, Castillo JJ. Human immunodeficiency virus-associated lymphomas in the antiretroviral therapy era: analysis of the national cancer data base. Cancer. 2016;122(17):2689–2697. doi:10.1002/cncr.30112.
   PubMed Web of Science ®Google Scholar